Option 2 Tablet
NDC Package 0113-8099-12

11-digit billing NDC: 00113809912
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Option 2 (levonorgestrel) tablets is •take as soon as possible within 72 hours (3 days) after unprotected sex. This formulation utilizes a tablet delivery system. Marketed by L. Perrigo Company, this product is identified by NDC 0113-8099 and is authorized under FDA application ANDA202334.

Identification & Billing

NDC Package Code
0113-8099-12
Package Description
1 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
Product Code
0113-8099
11-Digit Billing Format
00113809912
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Option 2
Non-Proprietary Name
Levonorgestrel
Substance Name
Levonorgestrel
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LEVONORGESTREL 1.5 mg/1
Pharmacologic Class
Usage Information
•take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.•if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose

Regulatory & Marketing

Labeler Name
L. Perrigo Company
Product Type
Human Otc Drug
FDA Application #
ANDA202334
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-20-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0113-8099-12 identifies a specific commercial package of 1 blister pack in 1 carton / 1 tablet in 1 blister pack of Option 2, a human over the counter drug labeled by L. Perrigo Company. This tablet is formulated for oral use and contains levonorgestrel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L. Perrigo Company on April 20, 2026. The current certification is valid through December 31, 2027.

How is this L. Perrigo Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00113809912. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0113-8099-12
11-Digit CMS (5-4-2)
00113-8099-12

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.